Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.

Marco BandiniRaisa S PompeMichele MarchioniEmanuele ZaffutoGiorgio GandagliaNicola FossatiLuca CindoloFrancesco MontorsiAlberto BrigantiFred SaadPierre I Karakiewicz

Published in: International urology and nephrology (2017)

This population-based study provides the first evidence of improved CSM free survival and OM free survival in patients with de novo mPCa since the introduction of several systemic agents for CRPC patients.

Keyphrases

free survival
prostate cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
small cell lung cancer
squamous cell carcinoma
prognostic factors